Skip to content

Drug interactions

Lorlatinib + Simvastatin

Severity: Moderate

Lorlatinib and Simvastatin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lorlatinib is a moderate CYP3A4 inducer and may lower simvastatin concentrations, reducing its lipid-lowering efficacy. The effect is on efficacy rather than toxicity.

What this interaction means in plain words

Lorlatinib and Simvastatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lorlatinib belongs to Oncology; Simvastatin belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Lorlatinib induces CYP3A4, increasing the metabolism of simvastatin.

What to do

Monitor the lipid profile and consider a higher simvastatin dose within labeled limits or a statin not dependent on CYP3A4. Reassess after lorlatinib is stopped.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lorlatinib and Simvastatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lorlatinib with Simvastatin?

MediHelp rates the interaction as moderate. Lorlatinib and Simvastatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lorlatinib is a moderate CYP3A4 inducer and may lower simvastatin concentrations, reducing its lipid-lowering efficacy. The effect is on efficacy rather than toxicity.

How serious is the interaction between Lorlatinib and Simvastatin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor the lipid profile and consider a higher simvastatin dose within labeled limits or a statin not dependent on CYP3A4. Reassess after lorlatinib is stopped.

What other medicines interact with Simvastatin?

MediHelp also lists interactions of Simvastatin with, for example, Atazanavir, Clarithromycin, Cobicistat. The full list is on the Simvastatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in